Article Text

Download PDFPDF
Hepatitis E virus finds its path through the gut
  1. Noémie Oechslin,
  2. Darius Moradpour,
  3. Jérôme Gouttenoire
  1. Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
  1. Correspondence to Dr. Jérôme Gouttenoire, Division of Gastroenterology and Hepatology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; Jerome.Gouttenoire{at}chuv.ch

Statistics from Altmetric.com

Hepatitis E virus (HEV) infection is a major cause of acute hepatitis and jaundice worldwide.1 HEV genotypes (gt) 1 and 2 are transmitted through the faecal-oral route and cause primarily waterborne epidemics, whereas the zoonotic gt 3 and 4 are transmitted via the consumption of undercooked or raw pork or game meat. Infection of immunocompromised patients with HEV gt 3 may result in chronic hepatitis E and the development of cirrhosis. Beyond liver disease, HEV can cause a number of extrahepatic manifestations, including neurological complications such as neuralgic amyotrophy and Guillain-Barré syndrome. Very similar to hepatitis A virus (HAV), HEV harbours a positive-strand RNA genome, and both are found as so-called quasi-enveloped virions in blood and as naked virions in bile and faeces.2

Although HEV is known to be enterically transmitted, there was limited evidence for infection of the gastrointestinal tract. In a study published in this journal, Marion et al addressed this question by the development of different cell culture systems, including primary human small intestinal epithelial cells, polarised primary enterocytes and intestinal tissue specimens obtained from small bowel resections.3 Using primary HEV gt 1 and 3 isolates from stool samples of patients with hepatitis E as well as virus derived from the gt 3 Kernow-C1 p6 clone, the …

View Full Text

Footnotes

  • Contributors NO, DM and JG wrote the manuscript.

  • Funding The authors acknowledge support by the Swiss National Science Foundation (grant number 31003A_179424) and the Gilead Sciences International Research Scholars Program in Liver Disease.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Hepatology
    Olivier Marion Sebastien Lhomme Manon Nayrac Martine Dubois Mélanie Pucelle Mary Requena Marion Migueres Florence Abravanel Jean Marie Peron Nicolas Carrere Bertrand Suc Pierre Delobel Nassim Kamar Jacques Izopet